Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy ...

“With submission in Canada and the UK, ARS Pharma now has approval or has filed for approval in jurisdictions comprising more ...

In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose of neffy in the same nostril with a new nasal spray starting 5 minutes after the ...

INDICATION AND IMPORTANT SAFETY INFORMATION FOR neffy (epinephrine nasal spray) INDICATION neffy 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

“The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly improves access to life-saving allergy treatment,” said Sal Grausso, Head of Market Access at ARS Pharma.

neffy 2 mg is for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh ≥30 kg (66 lbs.). It is the first and only FDA-approved epinephrine nasal spray ...

(MENAFN- GlobeNewsWire - Nasdaq) Licensing partners in key Asia Pacific countries have filed for approval of neffy (epinephrine nasal spray) 2 mg with regulatory agencies SAN DIEGO, Dec. 12 ...